Featured Research

from universities, journals, and other organizations

Errors In Cancer Diagnosis Put Patients In Harm's Way

Date:
October 10, 2005
Source:
John Wiley & Sons, Inc.
Summary:
Procedures used to obtain and examine tissue for cancer diagnosis are prone to error that frequently results in harm, according to a new study. Agency for Healthcare Research and Quality-funded researchers say that a governmentally mandated error detection method that involves the review of patient specimens, when patients have two or more specimens from the same body site, found up to 12 percent of reviewed specimen pairs had an erroneous diagnosis. However, pathologists failed to agree on the cause of most of these errors.

Procedures used to obtain and examine tissue for cancer diagnosis areprone to error that frequently results in harm, according to a newstudy published in the November 15, 2005 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom),a peer-reviewed journal of the American Cancer Society. Agency forHealthcare Research and Quality-funded researchers say that agovernmentally mandated error detection method that involves the reviewof patient specimens, when patients have two or more specimens from thesame body site, found up to 12 percent of reviewed specimen pairs hadan erroneous diagnosis. However, pathologists failed to agree on thecause of most of these errors.

The frequency and cause of errors in cancer diagnosis has not beenwell studied partly because of the lack of national standards to detecterrors. To characterize the frequency, cause, and impact of errors incancer diagnosis, Stephen S. Raab, M.D. of the University of PittsburghSchool of Medicine and colleagues reviewed tissue specimens,pathologists' findings, and medical records from four institutions thatdiagnose precancerous and cancerous lesions. Patients often havemultiple tests in order to diagnose cancer, and the researchersreviewed patient material when the diagnoses differed on multiple testsfrom the same patient.

They found that errors were relatively frequent andinstitution-dependent. Up to 9 percent of gynecologic specimen pairs(Pap test and cervical biopsy) contained an error and up to 12 percentof non-gynecologic specimen pairs contained an error. Differences ininstitutional error rates are most likely related to bias in errorreporting, although underlying quality improvement methods may haveresulted in lower error frequencies at some institutions.

The majority of errors were a result of sub-optimal specimencollection, and the proportion of errors caused by pathologistmisinterpretation ranged from 5 percent to 50 percent. Whenpathologists reviewed specimens from other institutions they frequentlydisagreed with the assignment of error cause.

Review of medical records showed that gynecologic errorsresulted in harm in 45 percent of cases and non-gynecologic errorsresulted in harm in 39 percent of cases. Harm most likely consisted indelays in diagnosis and additional testing that drove up healthcarecosts. It is very rare that unneeded procedures are performed for thefalse positive diagnosis of cancer. Pathologists also disagreed on theseverity of harm that was caused by an error in cancer diagnosis.

The researchers say that their study demonstrates not only arelatively high frequency of error using this detection method, butthat variability in practice impairs the ability to understand errorcause. To that end, "the standardization and uniform reporting oferrors in cancer diagnosis is a first step in improving safety,"conclude the authors.

###

Article: "Clinical Impact and Frequency of Anatomic Pathology Errorsin Cancer Diagnoses," Stephen S. Raab, Dana Marie Grzybicki, Janine E.Janosky, Richard J. Zarbo, Frederick A. Meier, Chris Jensen, andStanley J. Geyer, CANCER; Published Online: Monday, October 10, 2005(DOI: 10.1002/cncr.21431); Print Issue Date: November 15, 2005.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Errors In Cancer Diagnosis Put Patients In Harm's Way." ScienceDaily. ScienceDaily, 10 October 2005. <www.sciencedaily.com/releases/2005/10/051010085921.htm>.
John Wiley & Sons, Inc.. (2005, October 10). Errors In Cancer Diagnosis Put Patients In Harm's Way. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2005/10/051010085921.htm
John Wiley & Sons, Inc.. "Errors In Cancer Diagnosis Put Patients In Harm's Way." ScienceDaily. www.sciencedaily.com/releases/2005/10/051010085921.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins